Position in GH
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$4,962,485
New position
Shares Held
53,724
first reported quarter
Ownership
0.041%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Slow Capital, Inc. holds $37,385,397 across 6 Diagnostics & Research names. GH ranks #4 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GRAL |
GRAIL, Inc.
|
228,256 | $11,796,270 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
6,054 | $7,635,304 | |
| 3 | ILMN |
Illumina, Inc.
|
52,174 | $6,430,967 | |
| 4 | GH |
Guardant Health, Inc.
This page
|
53,724 | $4,962,485 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
8,061 | $3,962,223 | |
| 6 | WGS |
GeneDx Holdings Corp.
|
40,457 | $2,598,148 |
All Filings in GH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,962,485 | 53,724 | Shares | Sole | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||